Free Trial

Oppenheimer & Co. Inc. Acquires Shares of 19,729 MultiPlan Co. (NYSE:MPLN)

MultiPlan logo with Medical background
Remove Ads

Oppenheimer & Co. Inc. acquired a new position in shares of MultiPlan Co. (NYSE:MPLN - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 19,729 shares of the company's stock, valued at approximately $292,000. Oppenheimer & Co. Inc. owned approximately 0.12% of MultiPlan as of its most recent SEC filing.

Separately, Beach Point Capital Management LP grew its stake in shares of MultiPlan by 9.2% during the fourth quarter. Beach Point Capital Management LP now owns 384,982 shares of the company's stock worth $5,690,000 after acquiring an additional 32,582 shares during the last quarter. 87.15% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Citigroup increased their price objective on shares of MultiPlan from $10.00 to $12.50 and gave the company a "neutral" rating in a research report on Friday, January 10th.

Check Out Our Latest Research Report on MultiPlan

MultiPlan Stock Performance

MPLN stock traded down $0.91 during midday trading on Wednesday, reaching $17.35. The stock had a trading volume of 72,340 shares, compared to its average volume of 106,118. The firm has a fifty day simple moving average of $19.50. MultiPlan Co. has a 52-week low of $4.80 and a 52-week high of $37.61. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 21.73. The firm has a market cap of $280.57 million, a PE ratio of -0.18 and a beta of 0.13.

Remove Ads

MultiPlan Profile

(Free Report)

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.

Featured Stories

Institutional Ownership by Quarter for MultiPlan (NYSE:MPLN)

Should You Invest $1,000 in MultiPlan Right Now?

Before you consider MultiPlan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.

While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads